MetLife Investment Management’s Merit Medical Systems MMSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.21M | Sell |
32,040
-638
| -2% | -$49.8K | 0.01% | 1009 |
|
|
2025
Q4 | $2.88M | Sell |
32,678
-1,573
| -5% | -$134K | 0.01% | 888 |
|
|
2025
Q3 | $2.85M | Sell |
34,251
-603
| -2% | -$52.5K | 0.01% | 912 |
|
|
2025
Q2 | $3.26M | Sell |
34,854
-3,897
| -10% | -$369K | 0.02% | 772 |
|
|
2025
Q1 | $4.1M | Buy |
38,751
+4,166
| +12% | +$430K | 0.02% | 721 |
|
|
2024
Q4 | $3.35M | Buy |
34,585
+1,557
| +5% | +$155K | 0.02% | 781 |
|
|
2024
Q3 | $3.26M | Hold |
33,028
| – | – | 0.02% | 772 |
|
|
2024
Q2 | $2.84M | Buy |
33,028
+3,649
| +12% | +$287K | 0.02% | 809 |
|
|
2024
Q1 | $2.23M | Sell |
29,379
-594
| -2% | -$45.9K | 0.02% | 908 |
|
|
2023
Q4 | $2.28M | Hold |
29,973
| – | – | 0.02% | 895 |
|
|
2023
Q3 | $2.07M | Hold |
29,973
| – | – | 0.02% | 889 |
|
|
2023
Q2 | $2.51M | Buy |
29,973
+757
| +3% | +$61.6K | 0.02% | 842 |
|
|
2023
Q1 | $2.16M | Sell |
29,216
-540
| -2% | -$37.9K | 0.02% | 885 |
|
|
2022
Q4 | $2.1M | Hold |
29,756
| – | – | 0.02% | 877 |
|
|
2022
Q3 | $1.68M | Buy |
29,756
+1,163
| +4% | +$67K | 0.01% | 952 |
|
|
2022
Q2 | $1.55M | Hold |
28,593
| – | – | 0.01% | 1003 |
|
|
2022
Q1 | $1.9M | Buy |
28,593
+10,143
| +55% | +$610K | 0.01% | 1018 |
|
|
2021
Q4 | $1.15M | Hold |
18,450
| – | – | 0.01% | 1072 |
|
|
2021
Q3 | $1.32M | Hold |
18,450
| – | – | 0.01% | 1004 |
|
|
2021
Q2 | $1.19M | Sell |
18,450
-3,158
| -15% | -$195K | 0.01% | 1079 |
|
|
2021
Q1 | $1.29M | Hold |
21,608
| – | – | 0.01% | 1022 |
|
|
2020
Q4 | $1.2M | Sell |
21,608
-1,953
| -8% | -$101K | 0.01% | 1047 |
|
|
2020
Q3 | $1.02M | Hold |
23,561
| – | – | 0.01% | 1014 |
|
|
2020
Q2 | $1.08M | Hold |
23,561
| – | – | 0.01% | 1000 |
|
|
2020
Q1 | $736K | Hold |
23,561
| – | – | 0.01% | 1028 |
|
|
2019
Q4 | $736K | Hold |
23,561
| – | – | 0.01% | 1254 |
|
|
2019
Q3 | $718K | Hold |
23,561
| – | – | 0.01% | 1227 |
|
|
2019
Q2 | $1.4M | Hold |
23,561
| – | – | 0.02% | 965 |
|
|
2019
Q1 | $1.46M | Hold |
23,561
| – | – | 0.02% | 933 |
|
|
2018
Q4 | $1.31M | Hold |
23,561
| – | – | 0.02% | 927 |
|
|
2018
Q3 | $1.45M | Buy |
23,561
+251
| +1% | +$14.4K | 0.01% | 986 |
|
|
2018
Q2 | $1.19M | Hold |
23,310
| – | – | 0.01% | 955 |
|
|
2018
Q1 | $1.06M | Hold |
23,310
| – | – | 0.01% | 985 |
|
|
2017
Q4 | $1.01M | Buy |
+23,310
| New | +$978K | 0.01% | 1031 |
|
Other funds holding MMSI
VPM
VCM
CCA
NAMI
MetLife Investment Management's MMSI Position: Q1 2026 in Review
MetLife Investment Management reduced its Merit Medical Systems (MMSI) stake by 2% in Q1 2026, selling an estimated $49.8K and leaving 32,040 shares worth $2.21M. The position accounts for 0.01% of the portfolio, ranked #1009.
MetLife Investment Management first reported a position in MMSI in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.1M in Q1 2025. 399 funds tracked by Wall St. Rank hold MMSI as of Q1 2026.
- MetLife Investment Management held 32,040 shares of Merit Medical Systems worth $2.21M as of Q1 2026.
- MetLife Investment Management sold 638 Merit Medical Systems shares in Q1 2026, an estimated $49.8K.
- Merit Medical Systems made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1009 holding.
- MetLife Investment Management first reported a position in Merit Medical Systems in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Merit Medical Systems position peaked at $4.1M in Q1 2025.
- 399 funds tracked by Wall St. Rank held Merit Medical Systems as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.